Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling.

Wang Y, Cai Q.

Open source

DOI
10.2147/bctt.s615413
Published
2026-07-27
Container
Breast Cancer (Dove Med Press)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/bctt.s615413,
  title = {Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling.},
  author = {Wang Y and  Cai Q.},
  year = {2026},
  journal = {Breast Cancer (Dove Med Press)},
  doi = {10.2147/bctt.s615413},
  url = {https://doi.org/10.2147/bctt.s615413}
}

RIS

TY  - JOUR
TI  - Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling.
AU  - Wang Y
AU  -  Cai Q.
PY  - 2026
JO  - Breast Cancer (Dove Med Press)
DO  - 10.2147/bctt.s615413
UR  - https://doi.org/10.2147/bctt.s615413
ER  - 

APA

Y, W., & Q., C. (2026). Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling.. Breast Cancer (Dove Med Press). https://doi.org/10.2147/bctt.s615413

Source records